Pieternella J. Lugtenburg

Second Cancer Risk Up to 40 Years after Treatment for Hodgkin’s Lymphoma

Michael Schaapveld, Berthe M.P. Aleman, Anna M. van Eggermond et al. · New England Journal of Medicine · 2015 · 605 citations · Full text

Treatment of Older Patients with Mantle-Cell Lymphoma

Hanneke C. Kluin‐Nelemans, Eva Hoster, Olivier Hermine et al. · New England Journal of Medicine · 2012 · 511 citations · Full text

Prevention of Catheter-Related Bacteremia with a Daily Ethanol Lock in Patients with Tunnelled Catheters: A Randomized, Placebo-Controlled Trial

Lennert Slobbe, Jeanette K. Doorduijn, Pieternella J. Lugtenburg et al. · PLoS ONE · 2010 · 497 citations · Full text

Epcoritamab, a Novel, Subcutaneous CD3xCD20 Bispecific T-Cell–Engaging Antibody, in Relapsed or Refractory Large B-Cell Lymphoma: Dose Expansion in a Phase I/II Trial

Catherine Thiéblemont, Tycel Phillips, Hervé Ghesquières et al. · Journal of Clinical Oncology · 2022 · 484 citations · Full text

Chemotherapy plus Involved-Field Radiation in Early-Stage Hodgkin's Disease

Christophe Fermé, Houchingue Eghbali, J.H. Meerwaldt et al. · New England Journal of Medicine · 2007 · 444 citations · Full text